Multicellular living organisms and unmodified parts thereof and – Method of making a transgenic nonhuman animal
Reexamination Certificate
2007-09-27
2009-08-18
Ton, Thaian N (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Method of making a transgenic nonhuman animal
C800S025000
Reexamination Certificate
active
07576259
ABSTRACT:
Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a significant contribution to all tissues from the donor cells and is capable of transmitting the donor cell DNA.
REFERENCES:
patent: 6485972 (2002-11-01), McMahon et al.
patent: 7294754 (2007-11-01), Poueymirou et al.
patent: WO 2005/012511 (2005-02-01), None
Adbelmassih et al. (2002) Laser-assisted ICSI: a novel approach to obtain higher oocyte survival and embryo quality . . . Human Reprod. 17/10:2694-2699.
Cotta-de-Almeida et al. (2003) A New Method for Rapidly Generating Gene-Targeting Vectors by Engineering BACs Through . . . Genome Res. 13:2190-2194.
Denning, C. et al. (2003) New frontiers in gene targeting and cloning: success, application and challenges in domestic . . . Reproduction 126:1-11.
Eggan et al. (2002) Male and female mice derived from the same embryonic stem celll clone by tetraploid embryo . . . Nature Biotech. 20:455-459.
Eggan et al. (2001) Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid . . . PNAS 98/11:6209-6214.
Ogawa, K. et al. (2006) Synergistic action of Wnt and LIF in maintaining pluripotenoy of mouse ES cells. Biochem. Biophys. Res. Commun. 343:159-166.
Poueymirou et al. (2007) F0 generation mice fully derived from gene-targeted embryonic stem cells . . . Nature Biotech. 25:91-99.
Reya, T. et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-414.
Sato, N. et al. (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt . . . Nature Med. 10/1:55-63.
Shibamoto S. et al. (1998) Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes to Cells 3:659-670.
Tokunaga et al. (1992) Effioacious Production of Viable Germ-Line Chimeras between Embryonic Stem (ES) . . . Develop. Growth & Differ. 34/5:561-566.
Yagi, A. et al. (1993) A Novel ES Cell Line, TT2, with High Germline-Differentiating Potency. Analytical Biochem. 214:70-76.
Zand et al. (2000) Interleukin-2 and Interferon-gamma Double Knockout Mice Reject Heterotopic Cardiac Allografts. Transplantation 70/9:1378-1381.
International Search Report for PCT/US2005/037584 (4 pages), Jan. 23, 2006.
International Preliminary Report on Patentability for PCT/US2005/037584 (7 pages), Apr. 24, 2007.
Dalton et al. (1993) Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-gamma Genes. Science 259:1739-1742.
Auerbach Wojtek
DeChiara Thomas M.
Frendewey David
Poueymirou William
Valenzuela David M.
Gregg, Esq. Valeta
Noble Marcia S
Regeneron Pharmaceuticals Inc.
Smeland, Esq. Tor E.
Ton Thaian N
LandOfFree
Method for making genetic modifications does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for making genetic modifications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for making genetic modifications will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4062447